Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

64.89 USD +0.23 (+0.36%)
Official Closing Price Updated: 6:27 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
A Short Delay Is Still Bad News for AbbVie
Rinvoq's FDA approval decision could be a sign the drug class is under investigation. 
Tags PFE INCY LLY
From Motley Fool
How To Play Lagging Healthcare Stocks
The Healthcare Select SPDR Fund (XLV​​​​​​​) gives you the most diversified play in healthcare returning 11.4% in ’20 and 4% YTD. 
Tags ETFs Stocks / Equities Healthcare
From Blogs - TalkMarkets
Notable Monday Option Activity: FAST, GILD, WMT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Fastenal Co. (FAST), where a total of 20,167 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Biotech Stocks Could Use A Win — Will The First Quarter Offer That?
Gilead Sciences, Biogen and Vertex Pharmaceuticals could top expectations in an otherwise soft quarter for biotech stocks, an analyst said Thursday. He sees key products beating forecasts. 
From Investor's Business Daily
A Look Into Gilead Sciences Price Over Earnings
Looking into the current session, Gilead Sciences Inc. (NASDAQ:GILD) shares are trading at $65.61, after a 0.1% ... 
Tags News GILD Markets
From Benzinga
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SGTX FDA LLY
From Benzinga
Is Gilead Sciences Stock a Buy?
This is one contrarian investment you don't want to miss out on. 
Tags IBB Market News GILD
From Motley Fool
Gilead's Trodelvy Wins FDA Regular Approval For Triple-Negative Breast Cancer
TheFDA has granted regular approvaltoGilead Sciences Inc's(NASDAQ:GILD) Trodelvy (sacituzumab ... 
Tags Market News breast cancer Benzinga
From Benzinga
Exclusive: Precigen's CEO Breaks Down Biotech's Oncology Platforms, Technology, Differentiators
Cancer treatment has evolved from the use of chemotherapeutic anti-tumor drugs to targeted therapies to monoclonal antibodies to ... 
Tags General PGEN oncology
From Benzinga
Why Phase 2 Trials Are Important To Investors (And Why I’m Enrolled In One)
The biotech sector tends to attract investors who are interested in exciting new medical advances and are drawn to big profits. There are lots of ways to invest in the sector. 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly
The following article is sponsored by Actinium Pharmaceuticals, Inc. The information contained in this article in no way represents ... 
Tags General VKTX News
From Benzinga
Easter Monday
With so many foreign markets closed, the boom was biggest for USA large caps. But there was enough fringe movement elsewhere as well. 
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
4 Biotech Stocks To Buy For The Q2 2021
The global biotechnology market is expected to expand at a CAGR of 15.8% between 2021 – 2028. 
Tags Market News Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Better Buy for 2021: Pfizer or Gilead?
In a post-pandemic world, one company has the lower valuation and higher dividend yield to be a success. 
Tags IHE BNTX Market News
From Motley Fool
Week In Review: Three China In-Licensing Deals Add Up To $662 Million
Simcere Pharma of Nanjing announced a $292 million agreement to develop a proposed Kazia Therapeutics treatment for glioma in Greater China. Qihan Biotechnology raised $67 million in a Series A++ round... 
Tags Market News Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
3 Dependable Dividend Stocks to Buy in April
Looking for a steady stream of income? These are companies you can count on. 
Tags ADP MRK GILD
From Motley Fool
Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake
It's never a bad time to search for beaten-down stocks that are profitable on paper. 
Tags GILD DKNG TUP
From Motley Fool
7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Covid-19 has put healthcare stocks in the limelight. These seven... 
Tags TMO ABT Market News
From InvestorPlace
Top Stocks To Buy Now? 4 Health Care Stocks To Watch
Tags Market News
From StockMarket.com
AbCellera, Gilead Ink New Multi-Target Antibody Discovery Collaboration
AbCellera Biologics Inc(NASDAQ:ABCL) hasannounced agreements to expand its collaborationwithGilead ... 
Tags News Biotech GILD
From Benzinga
This Big Leap in Cancer Treatment Could Change the Landscape
TIL therapy looks able to win a large addressable market, and Iovance is the leader of the pack. 
Tags Market News IOVA GILD
From Motley Fool
Gilead Sciences Bull Flag Breakout Nearing
Shares of Gilead Sciences have been chopping sideways over the last three months. This has formed a beautiful Gilead Sciences bull flag and sets up for a big breakout. 
Tags Stocks / Equities Healthcare Market News
From Blogs - TalkMarkets
Pharma and Biotech Stocks On Sale
Healthcare represents a fertile field for value-oriented investors seeking good investments that simultaneously provide a margin of safety. 
Tags Market News Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Could Regeneron's Antibody Therapy Be as Important as Vaccines in Fighting COVID?
There are a couple of obstacles that could get in the way. 
Tags Market News REGN GILD
From Motley Fool
Everest Approved for China Phase II trial of Trodelvy® in TROP-2 Cancers
Shanghai 's Everest Medicines said it is approved to conduct a China Phase II trial of Trodelvy® in patients with cancers that have high TROP-2 expression. Everest plans to enroll 180 patients with... 
From ChinaBio® Today
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2021
Upgrades According to Seaport Global, the prior rating for Clearway Energy Inc (NYSE:CWEN) was changed from Neutral to ... 
Tags TXN RNSHF FCEL
From Benzinga
Why Humanigen Stock Is Skyrocketing Today
The company's investigational coronavirus treatment could hit the market soon. 
Tags Market News HGEN LLY
From Motley Fool
Why Humanigen, uniQure, bluebird bio, Amphastar Are Rallying Monday
Humanigen, Inc. (NASDAQ: HGEN), uniQure N.V. (NASDAQ: QURE), bluebird bio, Inc. (NASDAQ: BLUE) and Amphastar Pharmaceuticals, Inc. ... 
Tags Market News BLUE Small Cap
From Benzinga
Best Stocks To Buy In April 2021? 4 Biotech Stocks To Watch This Week
Tags Market News
From StockMarket.com
Noteworthy ETF Outflows: IXJ, JNJ, ABT, GILD
Symbols mentioned in this story: IXJ, JNJ, ABT, GILD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.